During the data period, approximately 18.6 million Nexium prescriptions were written. Nexium came close on the heels of hypothyroidism drug levothyroxine (22.6 million prescriptions) and cholesterol-lowering drug Crestor (22.5 million prescriptions).
Nexium netted $6.3 billion in sales, tied with Humira for the second top-selling drug during the data period. Notably, hepatitis C drug Sovaldi generated $4.4 billion in sales.
More Articles on Gastroenterology:
Endoscopy device market to reach $36.9B in 2019
7 gastroenterologists making the news
Young gastroenterologists: the essential skills to thrive in healthcare today
